Pronitazene Stats & Data

Name harmonized to Protonitazene (Pronitazene is a common synonym/variant); authoritative databases list Protonitazene as the preferred name. Nitazenes (including protonitazene) are highly potent and have been increasingly detected in Europe and North America, often in counterfeit or mis-sold products (e.g., heroin lookalikes and fake oxycodone/benzodiazepine tablets). Fentanyl test strips do not detect nitazenes; do not rely on them to rule out nitazenes—use laboratory-grade drug checking where available. Due to potency, active at double-digit microgram doses with a steep dose–response; volumetric dosing and calibrated 0.1 mg (or better) scales are strongly advised. Overdose management: initial response is the same as for other opioids; multiple naloxone doses may be required for reversal with potent synthetic opioids; provide rescue breathing and seek emergency care. Nitazenes often co-occur with other CNS depressants (e.g., benzodiazepines, xylazine); such combinations substantially increase overdose risk. Multiple naloxone administrations may be needed and monitoring after reversal is important because naloxone’s duration is shorter than many opioids. Powder and tablets containing nitazenes have been confirmed by drug checking services in fake oxycodone and other pills; assume unknowns contain high-potency opioids unless proven otherwise. Human pharmacokinetics for protonitazene remain poorly characterized; avoid redosing to ‘chase’ effects. Powder appearance or color is not a reliable indicator of content; only lab testing can confirm identity.